Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s share price crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares traded.
Liberty Biopharma Price Performance
The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 8.19. The business has a 50-day moving average of C$2.00 and a 200 day moving average of C$2.00. The firm has a market capitalization of C$21.54 million and a PE ratio of -12.66.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Read More
- Five stocks we like better than Liberty Biopharma
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Apple’s Intel Deal Arrives at the Right Time for Its Stock
- Liquid Gold: The AI Cooling Retrofit Trade
- 3 Dividend Stocks Under $30 to Anchor Your Portfolio
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
